LATUDA

This brand name is authorized in Austria, Australia, Brazil, Canada, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, United Kingdom, United States

Active ingredients

The drug LATUDA contains one active pharmaceutical ingredient (API):

1 Lurasidone UNII O0P4I5851I - LURASIDONE HYDROCHLORIDE

Lurasidone is a selective blocking agent of dopamine and monoamine effects indicated for the treatment of schizophrenia. Lurasidone binds strongly to dopaminergic D2- and to serotonergic 5-HT2A and 5-HT7 receptors. Lurasidone does not bind to histaminergic or muscarinic receptors. Read about Lurasidone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LATUDA Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AE05		N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AE Indole derivatives
Discover more medicines within N05AE05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10526B, 10529E
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 530418030014102, 530418030014202, 530418030014302, 530418030014402, 530418030014502, 530418030014602, 530418030014702, 530418030014802, 530418030014902, 530418030015002, 530418030015102, 530418030015202
Country: CA	Health Products and Food Branch	Identifier(s): 02387751, 02387778, 02387786, 02413361, 02422050
Country: EE	Ravimiamet	Identifier(s): 1644162, 1644173, 1644184, 1644195, 1644207, 1644218, 1644229, 1644230, 1644241, 1644252, 1644263, 1644274, 1644285, 1644296, 1644308, 1644319, 1644320, 1644331, 1644342, 1644353, 1644364, 1849574
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 114913002, 114913009, 114913016
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 053309, 092535, 410432, 486157, 538197
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 266545, 266548, 266551, 368132, 375159, 375161, 375163, 376729, 381456, 381458, 381460
Country: HK	Department of Health Drug Office	Identifier(s): 64804, 64806, 67186
Country: IT	Agenzia del Farmaco	Identifier(s): 043335013, 043335025, 043335037, 043335049, 043335052, 043335064, 043335076, 043335088, 043335090, 043335102, 043335114, 043335126, 043335138, 043335140, 043335153, 043335165, 043335177, 043335189, 043335191, 043335203, 043335215
Country: JP	医薬品医療機器総合機構	Identifier(s): 1179061F1022, 1179061F2029, 1179061F3025, 1179061F4021
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1073059, 1073061, 1073062, 1073063, 1073064, 1073065, 1073066, 1073067, 1073068, 1073069, 1073070, 1073071, 1073072, 1073073, 1073074, 1073075, 1073076, 1073077, 1073078, 1073079, 1073080
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 118524, 118532, 132683
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100209033, 100302896, 100314379
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64570001, W64570002, W64570003, W64570004, W64570005, W64570006, W64570007, W64571001, W64571002, W64571003, W64571004, W64571005, W64571006, W64571007, W64572001, W64572002, W64572003, W64572004, W64572005, W64572006, W64572007
Country: SG	Health Sciences Authority	Identifier(s): 15088P, 15089P
Country: US	FDA, National Drug Code	Identifier(s): 63402-302, 63402-304, 63402-306, 63402-308, 63402-312, 70518-1812, 70518-1824